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Background
Ewing sarcoma (ES) is an aggressive bone
and soft tissue sarcoma that most
frequently occurs in adolescent patients.
The multimodal treatment for ES consists
of chemotherapy, radiation, and surgery.
Unfortunately, >10% of patients have
recurrent disease, indicating room for
improvement in radiation efficacy.
Radiation creates reactive oxygen species
that cause double strand breaks (DSB) to
tumor cell DNA in the presence of oxygen.
Thus, increasing oxygenation of tumors
may enhance radiation efficacy. Studies
have shown that exercise improves tumor
vascular function which enhances
oxygenation. We hypothesize that
exercise will enhance RT efficacy in an
A673 ES murine model. To test this, we
first determined the radiosensitivity of
ES cells in vitro.
Conclusions
The α/β ratio and BED will be used to
design a fractionation protocol to be
used in combination with treadmill
exercise in mice studies.
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We expect to calculate the metrics which
include the α/β ratio, where the α
components corresponds to non-repairable
lethal damage and β to repairable DSB
(linear quadratic model). These values are
statistically determined with Graphpad when
we build the Survival curve. In radiobiology,
we used the α/β as a reliable estimate of
radiation response. Late responding tissue
like sarcomas are characterized by a low
ratio (3 or lower). We expect this to be
reflected with our experiment. Knowing the
α/β, the BED can be determined. This
reflects the sensitivity to dose fractionation.
Materials and Methods
We performed clonogenic assays, the gold
standard in measuring radiosensitivity, on
A673 Ewing tumor cells in increasing
seeding densities (100, 200, 300, 500,
1000, 1500, 2000, 3000) in 6 well plates.
Plates were irradiated at 2, 4, 5, and 7Gy
with a clinical linear accelerator (6MV
photon beam), the same machine used to
treat patients. Backscatter and buildup
material were used to place the cells at a
water-equivalent depth of 10 cm during
irradiation mimicking the location of a
tumor in the human body. After 8-14 days,
colonies (50 cells) were stained using
Crystal Violet 0.5% and counted using
ImageJ. The plating efficiency (PE) and
survival fractions (SF) were calculated, and
the dose-survival curves were generated
by plotting the SF as a function of the dose
on a semi-logarithmic scale (Prism
Software) and fitted using linear quadratic
model.
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Fig. 2. Timeline of the clonogenic assay. Plates
are seeded with different cell densities and
irradiated after 24h with the LINAC. When
ready, the colonies are stained, scanned, and
enumerated using Fiji software.
Results
We first determined the appropriate seeding
density at 0Gy (100, 400, 800). After 12 days of
incubation at 400 and 800, we determined the
plating efficiency using the formula:
PE=Number of colonies/Number of cells plated.
Therefore, for the irradiation experiment, we
proceeded with a lower seeding density of
100 and 200 at 0Gy. The aim of the
clonogenic assay is to reach at least 10%
survival with one of the 4 doses plus 0Gy.
With increasing radiation dose, more cells
must be plated to achieve this survival goal
Fig. 1 (A). LINAC was used for external
beam radiation treatments of the plates
(B). Acrylic set-up was used for accurate
calibration of the radiotherapy beams, to
avoid dosimetry error and to mimic the body
https://www.mdcalc.com/radiation-biologically-effective-dose-bed-calculator
Fig. 6. Summary of the clonogenic data. (A)
The SF of the replicates are similar for each
dose of radiation. (B) Survival curve of all
data.
Fig. 3. Plating efficiency of A673 at 0Gy. (A) Set
up. In this experiment seeding densities of 100,
400 and 800 were tested. (B) Summary of
colonies counted and PE determination. (C)
Colonies stained using a crystal violet solution
(0.5%) were scanned using Black & White
negative, Epson scanner.
Fig. 4. (A) Set-up of the clonogenic assays
in 6-well plates. We plated four batches of
A673 cells for more experimental accuracy.
(B) Wells were loaded according to the
experimental set-up. (C) Plate replicates
assigned the same dose were arranged in
acrylic build-up material 24 hours after plating.
Fig. 7 Extension of in vitro experiment to
murine model timeline
Fig. 5. (A) Representative clonogenic assay
of A673 cell line. (B) Enumeration of the
colonies (C) Radiation cell survival curve for
A673 cells.
Table. 1 Possible fractionation protocol for
murine model. For patients, the BED should be
>100 to achieve 85% of local tumor control. To
have the same effect, murine models should
have a BED>150. Conventional radiation
therapy using 2Gy/fraction over a period of 6
weeks. For the mice mice experiment, we
could use an hypofractionated protocol.




We performed 3 more replicates of the
A673 clonogenic assays. Figure 5
shows a dose dependent decrease of
the survival fraction shows that the
10% survival is likely to obtained with a
dose of ___Gy for all batches.
